CORCEPT THERAPEUTICS INC Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- CORCEPT THERAPEUTICS INC stock issued during period, value, stock options exercised for the quarter ending 2026-06-30 was $19.41M, a 28.35% increase year-over-year.
- CORCEPT THERAPEUTICS INC stock issued during period, value, stock options exercised for the quarter ending 2026-03-31 was $10.86M, a 15.80% decline year-over-year.
- CORCEPT THERAPEUTICS INC stock issued during period, value, stock options exercised for the quarter ending 2025-09-30 was $9.94M, a 3.66% decline year-over-year.
- CORCEPT THERAPEUTICS INC stock issued during period, value, stock options exercised for the quarter ending 2025-06-30 was $15.12M, a 99.67% increase year-over-year.
- CORCEPT THERAPEUTICS INC stock issued during period, value, stock options exercised for fiscal 2025 was $50.05M, a 62.42% increase from fiscal 2024.
- CORCEPT THERAPEUTICS INC stock issued during period, value, stock options exercised for fiscal 2024 was $30.81M, a 5.78% increase from fiscal 2023.
- CORCEPT THERAPEUTICS INC stock issued during period, value, stock options exercised for fiscal 2023 was $29.13M, a 2.27% increase from fiscal 2022.
- CORCEPT THERAPEUTICS INC stock issued during period, value, stock options exercised for fiscal 2022 was $28.48M, a 11.12% decline from fiscal 2021.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2026-06-30 | $19.41M 10-Q · filed 2026-07-29 | |
| 2026-03-31 | $10.86M 10-Q · filed 2026-07-29 | |
| 2025-12-31 | $50.05M 10-K · filed 2026-02-24 | |
| 2025-09-30 | $9.94M 10-Q · filed 2025-11-04 | |
| 2025-06-30 | $15.12M 10-Q · filed 2026-07-29 | |
| 2025-03-31 | $12.90M 10-Q · filed 2026-07-29 | |
| 2024-12-31 | $30.81M 10-K · filed 2026-02-24 | |
| 2024-09-30 | $10.32M 10-Q · filed 2025-11-04 | |
| 2024-06-30 | $7.57M 10-Q · filed 2025-11-04 | |
| 2024-03-31 | $3.48M 10-Q · filed 2025-11-04 | |
| 2023-12-31 | $29.13M 10-K · filed 2026-02-24 | |
| 2023-09-30 | $13.95M 10-Q · filed 2024-10-30 | |
| 2023-06-30 | $4.50M 10-Q · filed 2024-10-30 | |
| 2023-03-31 | $6.54M 10-Q · filed 2024-10-30 | |
| 2022-12-31 | $28.48M 10-K · filed 2025-02-26 | |
| 2022-09-30 | $12.23M 10-Q · filed 2023-11-01 | |
| 2022-06-30 | $6.60M 10-Q · filed 2022-11-03 | |
| 2022-03-31 | $6.54M 10-Q · filed 2023-11-01 | |
| 2021-12-31 | $32.05M 10-K · filed 2024-02-15 | |
| 2021-09-30 | $6.22M 10-Q · filed 2022-11-03 | |
| 2021-06-30 | $6.66M 10-Q · filed 2022-11-03 | |
| 2021-03-31 | $10.08M 10-Q · filed 2022-11-03 | |
| 2020-12-31 | $25.30M 10-K · filed 2023-02-28 | |
| 2020-09-30 | $6.02M 10-Q · filed 2021-11-03 | |
| 2020-06-30 | $7.64M 10-Q · filed 2021-11-03 | |
| 2020-03-31 | $480.00K 10-Q · filed 2021-11-03 | |
| 2019-12-31 | $10.40M 10-K · filed 2022-02-15 | |
| 2019-09-30 | $2.70M 10-Q · filed 2020-11-03 | |
| 2019-06-30 | $1.51M 10-Q · filed 2020-11-03 | |
| 2019-03-31 | $3.37M 10-Q · filed 2020-11-03 | |
| 2018-12-31 | $9.32M 10-K · filed 2021-02-23 | |
| 2018-09-30 | $634.00K 10-Q · filed 2019-11-07 | |
| 2018-06-30 | $4.04M 10-Q · filed 2019-11-07 | |
| 2018-03-31 | $1.92M 10-Q · filed 2019-11-07 | |
| 2017-12-31 | $7.18M 10-K · filed 2020-02-24 | |
| 2016-12-31 | $7.68M 10-K · filed 2019-02-26 | |
| 2015-12-31 | $5.19M 10-K · filed 2018-02-28 | |
| 2014-12-31 | $1.78M 10-K · filed 2017-03-06 | |
| 2013-12-31 | $55.00K 10-K · filed 2016-03-10 | |
| 2012-12-31 | $289.00K 10-K · filed 2015-03-13 | |
| 2011-12-31 | $371.00K 10-K · filed 2014-03-14 | |
| 2010-12-31 | $151.00K 10-K · filed 2013-03-15 | |
| 2008-12-31 | $4.00K 10-K · filed 2012-03-13 | |
| 2007-12-31 | $21.00K 10-K · filed 2012-03-13 | |
| 2006-12-31 | $19.00K 10-K · filed 2012-03-13 | |
| 2005-12-31 | $1.00K 10-K · filed 2012-03-13 | |
| 2004-12-31 | $1.00K 10-K · filed 2012-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |